MARÍA ITZIAR
POCHEVILLE GURUCETA
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (38)
2021
2020
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2019
2016
-
High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study
Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307
2014
-
Predictive factors of severe multilobar pneumonia and shock in patients with influenza
Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307
2013
-
Hereditary pulmonary alveolar proteinosis. Could it be triggered by Mycoplasma pneumoniae pneumonia?
Respiratory Medicine, Vol. 107, Núm. 1, pp. 134-138
-
Risk factors and effectiveness of preventive measures against influenza in the community
Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183
2012
-
Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization
Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439
-
Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents
Pediatric Infectious Disease Journal, Vol. 31, Núm. 3, pp. 273-277
-
Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745
2011
-
Estudio de contactos en niños y adolescentes usando el QuantiFERON-TB® gold in-tube
Anales de Pediatria, Vol. 74, Núm. 6, pp. 363-370
2010
-
Pneumococcal bacteremia in febrile infants presenting to the emergency department 8 years after the introduction of pneumococcal conjugate vaccine in the basque country of Spain
Pediatric Infectious Disease Journal, Vol. 29, Núm. 12, pp. 1142-1144
2007
-
Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain
Pediatric Infectious Disease Journal, Vol. 26, Núm. 8, pp. 667-671
-
Prevalencia de resistencia a fármacos antirretrovirales en España
Anales de Pediatria, Vol. 67, Núm. 2, pp. 104-108
-
Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Núm. 5, pp. 303-310
2005
-
Abnormalities in plasma fatty acid composition in human immunodeficiency virus-infected children treated with protease inhibitors
Acta Paediatrica, International Journal of Paediatrics, Vol. 94, Núm. 6, pp. 672-677
-
Safety and antiviral response at 12 months of lopinavir/ritonavir therapy in human immunodeficiency virus-1-infected children experienced with three classes of antiretrovirals
Pediatric Infectious Disease Journal, Vol. 24, Núm. 10, pp. 867-873
2004
2002
-
Estudio de la incidencia de enfermedad neumocócica invasora entre 0-5 años en el País Vasco y Navarra
Anales Espanoles de Pediatria, Vol. 57, Núm. 4, pp. 301-309
-
Meningitis neumocócica en niños Españoles: Incidencia, serotipos y resistencia antibiótica. Estudio prospectivo multicéntrico
Anales Espanoles de Pediatria, Vol. 57, Núm. 4, pp. 295-300